Randevu Hattı444 0 600
Randevu Al

Bilimsel Yayınlar

Prof. Dr. Metin Başaranoğlu'nun yazdığı ve katkı sağladığı tüm bilimsel yayınlara aşağıdan erişebilirsiniz. Yayınlara ulaşmak için linklere tıklayınız.
  1. Peng M, Bai Z, Zou D, Xu S, Wang C, Başaranoğlu M, Philips CA, Guo X, Shao X, Qi X. Timing of endoscopy in patients with cirrhosis and acute variceal bleeding: a single-center retrospective study. BMC Gastroenterol. 2023 Jun 26;23(1):219. doi: 10.1186/s12876-023-02766-8. PMID: 37365510; PMCID: PMC10291747.
  2. Romero-Gómez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, Kaufman KD, Engel SS; MK-6024 P001 Study Group. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. J Hepatol. 2023 Oct;79(4):888-897. doi: 10.1016/j.jhep.2023.05.013. Epub 2023 Jun 22. PMID: 37355043.
  3. Güney Coşkun M, Kolay E, Basaranoglu M. Telenutrition for the management of inflammatory bowel disease: Benefits, limits, and future perspectives. World J Clin Cases. 2023 Jan 16;11(2):308-315. doi: 10.12998/wjcc.v11.i2.308. PMID: 36686349; PMCID: PMC9850965.
  4. Demirel M, Köktaşoğlu F, Özkan E, Dulun Ağaç H, Gül AZ, Sharifov R, Sarıkaya U, Başaranoğlu M, Selek Ş. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2023 Jul-Dec;58(11):1344-1350. doi: 10.1080/00365521.2023.2225667. Epub 2023 Jun 20. PMID: 37337892.
  5. Zhaohui Bai,Nahum Méndez-Sánchez,Fernando Gomes Romeiro,Andrea Mancuso,Cyriac Abby Philips,Frank Tacke, Metin Basaranoglu,Massimo Primignani,Mostafa Ibrahim,Yu Jun Wong,Filipe Gaio Nery,Rolf Teschke,Carlos Noronha Ferreira,Alberto E. Muñoz et al. Use of albumin infusion for cirrhosis-related complications: an international position statement. JHEP Reports 2023 100785, ISSN 2589-5559, https://doi.org/10.1016/j.jhepr.2023.100785. (https://www.sciencedirect.com/science/article/pii/S2589555923001167)
  6. Toruner M, Basaranoglu M, Atug O, Senturk O, Akyuz F, Cekic C, Over Hamzaoglu H, Tekin F, Sezgin O, Akpinar H, Celik AF, Tezel A, Gokturk HS, Kav T. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey. Turk J Gastroenterol. 2022 May;33(5):406-413. doi: 10.5152/tjg.2022.21868. PMID: 35678798.
  7. Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case-control study. Therap Adv Gastroenterol. 2022 May 11;15:17562848221087536. doi: 10.1177/17562848221087536. PMID: 35574427; PMCID: PMC9102139.
  8. Basaranoglu M, Kurtoglu A. Replacing the Name of NAFLD With a Metabolic or Another Forename as Indicator of the Era of Stagnation in NASH Studies. J Clin Gastroenterol. 2021 Jul 1;55(6):548-549. doi: 10.1097/MCG.0000000000001494. PMID: 33471489.
  9. Basaranoğlu M, Kapsigay M, Kunduz E. Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine. Eur J Gastroenterol Hepatol. 2020 Jun;32(6):763. doi: 10.1097/MEG.0000000000001693. PMID: 32355096.
  10. Ozkan E, Basaranoglu M. Recurrent ‘gloves and socks’ distribution with bullous eruptions after adalimumab and infliximab treatment in a patient with Crohn’s disease. Eur J Gastroenterol Hepatol. 2020 May;32(5):666-667. doi: 10.1097/MEG.0000000000001673. PMID: 32251208.
  11. Guney M, Basaranoglu M. A patient with Crohn’s disease during remission by biological agent treatment developed active pulmonary tuberculosis and determining the eating habits. Eur J Gastroenterol Hepatol. 2020 Apr;32(4):541-542. doi: 10.1097/MEG.0000000000001602. PMID: 31714388.
  12. Basaranoglu M. Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissue. Eur J Gastroenterol Hepatol. 2020 Mar;32(3):458. doi: 10.1097/MEG.0000000000001564. PMID: 32011389.
  13. David T Rubin, Iris Dotan, Aaron DuVall, Yoram Bouhnik, Graham Radford-Smith, Peter D R Higgins et al. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. The Lancet Gastroenterology & Hepatology, Volume 7, Issue 1, January 2022, Pages 17-27.
  14. Basaranoglu M, Najjar SM, et al. Rate and predictors of endoscopic mucosal healing in patients with inflammatory Bowel disease by azathioprine treatment. Journal of Gastrointestinal&Digestive System. 2016 6;4:1-5.
  15. Basaranoglu M, Najjar SM, Demirbag AE, Senturk H. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol. 2016 Mar 8;8(7):376-84. doi:10.4254/wjh.v8.i7.376.
  16. Gültepe İ, Başaranoğlu M, Zorlu M, Şenyiğit A, Taşkale EZ, Zaralı S, Atay K, Köroğlu E. Low lipase levels as an independent marker of pancreatic cancer: a frequently neglected condition in clinical setting. Turk J Gastroenterol. 2016 Mar;27(2):197-200. doi: 10.5152/tjg.2016.16056. PubMed PMID: 27015625.
  17. Ilhami Gultepe, Metin Basaranoglu, Yaser Suleymanoglu, Gokcen Basaranoglu and Fatma Beyazit. Ovaries are more vulnarable than hepatocytes for insulin resistance and hyperinsulinemia. Turk J Gastroenterol. 2016 Jan;27(1):62-7. doi: 10.5152/tjg.2015.150473. PubMed PMID: 26728862.
  18. Kayaçetin S, Başaranoğlu M. Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin. Turk J Gastroenterol. 2015 Nov;26(6):506-10. doi: 10.5152/tjg.2015.150199.
  19. Hardalaç F, Başaranoğlu M, Yüksel M, Kutbay U, Kaplan M, Özderin Özin Y, Kılıç ZM, Demirbağ AE, Coşkun O, Aksoy A, Gangarapu V, Örmeci N, Kayaçetin E. The rate of mucosal healing by azathioprine therapy and prediction by artificial systems. Turk J Gastroenterol. 2015 Jul;26(4):315-21. doi: 10.5152/tjg.2015.0199.
  20. Basaranoglu M, Canbakan B, Yildiz K, Ceylan B, Baysal B, Uysal O, Senturk H. Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives. Wien Klin Wochenschr. 2015 Apr 14. [Epub ahead of print] PubMed PMID: 25869759.
  21. Basaranoglu M, Sayilir A, Demirbag AE, Mathew S, Ala A, Senturk H. Seasonal clustering in inflammatory bowel disease: a single centre experience. Expert Rev Gastroenterol Hepatol. 2015 Mar 19:1-5. [Epub ahead of print] PubMed PMID: 25790731.
  22. Kalem F, Yüksekkaya S, Başaranoğlu M. The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas. Wien Klin Wochenschr. 2015 Apr 14. [Epub ahead of print] PubMed PMID: 25869760.
  23. Başaranoğlu M, Sayılır A, Yüksel M, Yıldız H, Suvak B, Turhan N, Tunç B, Özin Y. Characterization of de novo colonic stricture due to Crohn’s disease. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:S129-32. doi: 10.5152/tjg.2014.7677. PubMed PMID: 25910290.
  24. Ceylan B, Fincanci M, Muderrisoglu C, Soysal F, Eren G, and Basaranoglu M. Variables determining the virological response to adefovir treatment in patients with chronic HBV infectionpreviosly treated with lamuvidine. African Journal of Microbiology Research. 1-6;7(1) 2013. DOI:10.5897. AJMR/12.031.
  25. Neuschwander-Tetri BA, Ford DA, Acharya S, Gilkey G, Basaranoglu M, Tetri LH, Brunt EM. Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools. Lipids. 2012 Oct;47(10):941-50. PubMed PMID: 22923371; PubMed Central PMCID: PMC3473077.
  26. Yilmaz UE, Yilmaz N, Titiz I, Basaranoglu M, Tarcin O. The utility of amylase and lipase as reliable predictive markers for functioning renal graft. Ann Transplant. 2012 Jul-Sep;17(3):77-84. PubMed PMID: 23018259.
  27. Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo G, Whitcomb DC, Windsor JA; ; Basaranoglu M, Pancreatitis Across Nations Clinical Research and Education Alliance (PANCREA). Determinant-Based Classification of Acute Pancreatitis Severity: An International Multidisciplinary Consultation. Ann Surg. 2012 Dec;256(6):875-880. PubMed PMID: 22735715.
  28. Tarcin O, Basaranoglu M, Tahan V, Tahan G, Sücüllü I, Yilmaz N, Sood G, Snyder N, Hilman G, Celikel C, Tözün N. Time course of collagen peak in bile duct-ligated rats. BMC Gastroenterology. 2011 Apr 28;11:45.
  29. Eren OO, Artac M, Boruban MC, Yavas O, Arslan U, Basaranoglu M. Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience. Med Oncol. 2009 Dec 26 (4):386-92.
  30. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol. 2008Nov;295(5):G987-95.
  31. Basaranoglu M et al. Prevalence and Consultation Behavior of Self-Reported Rectal Bleeding by Face-to-Face Interview in an Asian Community. Digestion. 2008 Jan 30;77(1):10-15.
  32. Demirkok SS, Basaranoglu M, Coker E, Karayel T. Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis. Respirology. 2007;12:591-3.
  33. Demirkok SS, Basaranoglu M, Akinci ED, Karayel T. Analysis of 275 patients with sarcoidosis over a 38 year period; a single-institution experience. Respir Med. 2007;101:1147-54.
  34. Sipahi Demirkok S, Basaranoglu M, Dervis E, Bal M, Karayel T. Analysis of 87 patients with Löfgren’s syndrome and the pattern of seasonality of subacute sarcoidosis. Respirology. 2006;11:456-61.
  35. Demirkok SS, Basaranoglu M, Akbilgic O. Seasonal variation of the onset of presentations in stage 1 sarcoidosis. Int J Clin Pract. 2006 Nov;60(11):1443-50.
  36. G Basaranoglu, Basaranoglu M, et al. The efffects of valsalva manœuvres on venopuncture pain. ıÜüEur J Anaesthesiol. 2006;23:591-3.
  37. ıBasaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2015 Apr;4(2):109-16. doi: 10.3978/j.issn.2304-3881.2014.11.05. Review. PubMed PMID: 26005677 Central PMCID: PMC4405421.
  38. Basaranoglu M and Ormeci N. Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management. The Turkish Journal of Gastroenterology. Accepted for publication in 2014
  39. Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. PubMed PMID: 23482247; PubMed Central PMCID: PMC3587472. Cited by 13
  40. Basaranoglu M, Basaranoglu G, Sentürk H. From fatty liver to fibrosis: A tale of “second hit”. World J Gastroenterol. 2013 Feb 28;19(8):1158-65. doi: 10.3748/wjg.v19.i8.1158. PubMed PMID: 23483818; PubMed Central PMCID: PMC3587471.
  41. Yavuz B, Kekkilli M, Haznedaroglu IC, Kayacetin E and Basaranoglu M. Ankaferd Blood Stoper in the management of gastrointestinal bleeding diseases. World J Gastroenterol. 2011 Sep 21;17(35):3962-70.
  42. Basaranoglu M, Turhan N, Sonsuz A, Basaranoglu G. Mallory Denk Bodies in chronic liver diseases. World J Gastroenterol. 2011 May 7;17(17):2172-7.
  43. Basaranoglu M and Basaranoglu G. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol. 2011 Sep 28;17(36):4055-62
  44. Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2010 May 14;16(18):2223-6.
  45. Basaranoglu M and Neuschwander-Tetri Brent A. ıÜüNonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. Gastroenterology & Hepatology. 2006;2:282-291.
  46. Basaranoglu M, O Acbay, and A Sonsuz. A controlled trial of gemfibrozil in the treatment of patients with NASH. J Hepatol. 1999; 31: 384.
  47. Ipekci S, Basaranoglu M, et al. The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol. 2003;4:371.
  48. Basaranoglu M. Serum levels of triglyceride and insulin resistance in patients with NASH. Can J Gastroenterol. 2002;16:813-4.
  49. Sonsuz A, Basaranoglu M, et al. Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2002;97:495.
  50. Basaranoglu M, A Sonsuz et al. The low incidence of primary liver disease in patients with nonalcoholic steatohepatitis. J Hepatol. 2001;35:684-5.
  51. Sonsuz A, Basaranoglu M, et al. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2000;95:1370-16.
  52. Basaranoglu M et al. Considerations in seasonal variation studies in IBD and re-evaluation of Aratari et al.’s seasonality results. Dig Liver Dis. 2006 Sep;38(9):710-1.
  53. Basaranoglu M. Symptom date is better than the endoscopic diagnosis date in seasonal variation studies in IBD. Am J Gastroenterol. 2006 Nov;101(11):2668-9.
  54. Basaranoglu M, Balci NC. A true fundic diverticulum of the gallbladder. J Gastroenterol Hepatol. 2006 Jul;21(7):1222-3.
  55. Basaranoglu M, Balci NC, Klor HU. Gallbladder sludge and acute pancreatitis induced by acute hepatitis A. ıÜüPancreatology. 2006;6:141-4.
  56. Basaranoglu M, Balci NC, Klor HU. Anomalous pancreaticobiliary junction (APBJ) with the drainage of the uncinate process into the minor papilla: demonstration by MRI. Br J Radiol. 2005;78:655-8.
  57. Basaranoglu M, Balci NC. Recurrent cholangitis associated with biliary sludge and Phrygian cap anomaly diagnosed by magnetic resonance imaging and magnetic resonance cholangio-pancreatography despite normal ultrasound and computed tomography. Scand J Gastroenterol. 2005;40:736-40.
  58. G Basaranoglu, Basaranoglu M. Behcet’s disease complicated with celiac trunk aneurysm. J Clin Gastroenterol. 2001;33:174-5.
  59. Basaranoglu M, et al. Spontaneous perirenal hematoma as the initial manifestation of polyarteritis nodosa and long-term follow-up without treatment. Nephron. 2000; 85: 279-80.
  60. Basaranoglu M, et al. A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous bilateral perirenal and subcapsular splenic haemorrhage.Rheumatology. 1999;38:794-6. Cited by 6
  61. Basaranoglu M, et al. A case of fibrosing mediastinitis with obstruction of superior vena cava and downhill esophageal varices: a rare cause of upper gastrointestinal hemorrhage. J Clin Gastroenterol. 1999; 28: 268-70.
  62. Basaranoglu M, et al. A case of cervical Brucella spondylitis with paravertebral abscess and neurological deficits. Scand J Infect Dis. 1999;31: 214-5.
  63. Sonsuz A, Basaranoglu M, et al. Amebic abscess of the caudate lobe with spontaneous rupture into the biliary tract., J Clin Gastroenterol. 1998;26:355-6.
  64. Basaranoglu M, et al. Primary pelvic hydatid cyst. J Clin Gastroenterol. 1998;26:157-8.
https://metinbasaranoglu.com.tr/wp-content/uploads/2024/03/Prof.-Dr.-Metin-Basaranoglu.png

Prof. Dr. Metin Başaranoğlu (Gastroenterolog ve Hepatolog)

Bezmialem Vakıf Ünivesitesi (BAVÜ) Gastroenteroloji Hepatoloji Bölümü Öğretim Üyesi

Menü
Faydalı Linkler
İletişim
444 0 600
metin_basaranoglu@yahoo.com
Adnan Menderes Bulvarı (Vatan Cad.) P.K. 34093 Fatih / İstanbul

©2023 Prof.Dr. Metin Başaranoğlu. All rights reserved. | Digibus tarafından yapılmıştır.